First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
about
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right TimeA Critical Overview of Targeted Therapies for GlioblastomaTherapeutic Immunization against GlioblastomaBlockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy
P2860
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
First results on survival from ...... newly diagnosed glioblastoma.
@en
First results on survival from ...... newly diagnosed glioblastoma.
@nl
type
label
First results on survival from ...... newly diagnosed glioblastoma.
@en
First results on survival from ...... newly diagnosed glioblastoma.
@nl
prefLabel
First results on survival from ...... newly diagnosed glioblastoma.
@en
First results on survival from ...... newly diagnosed glioblastoma.
@nl
P2093
P2860
P50
P1476
First results on survival from ...... newly diagnosed glioblastoma.
@en
P2093
Andrew E Sloan
Andrew J Brenner
Anthony E Maida
Arnold B Etame
Charles S Cobbs
Christopher Duma
Clement P Pillainayagam
Daniela A Bota
David D Tran
David E Avigan
P2860
P2888
P356
10.1186/S12967-018-1507-6
P577
2018-05-29T00:00:00Z
P6179
1104245321